4,452
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Dysfunctional adiposity index as a marker of adipose tissue morpho-functional abnormalities and metabolic disorders in apparently healthy subjects

, ORCID Icon, ORCID Icon, , ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 142-152 | Received 02 Dec 2020, Accepted 17 Feb 2021, Published online: 16 Mar 2021

References

  • Baker P, Machado P, Santos T, et al. Ultra‐processed foods and the nutrition transition: global, regional and national trends, food systems transformations and political economy drivers. Obes Rev. 2020;1–22. DOI:https://doi.org/10.1111/obr.13126.
  • Endalifer ML, Diress G. Epidemiology, predisposing factors, biomarkers, and prevention mechanism of obesity: a systematic review. J Obes. 2020;2020:6134362.
  • Anekwe CV, Jarrell AR, Townsend MJ, et al. Socioeconomics of obesity. Curr Obes Rep. 2020;9:272–279.
  • https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight reviewed on 2020 Aug 10
  • Development initiative, global nutrition report 2017: nourishing the SDGs, Development Initiatives, Bristol, UK, 2017
  • Van DI, Kromhout D, Geleijnse JM, et al. Verschuren WM: body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20-65 years. Eur J Cardiovasc Prev Rehabil. 2009;16:729–734.
  • Guilherme A, Virbasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:367–377.
  • Banack HR, Wactawski-Wende J, Hovey KM, et al. BMI a valid measure of obesity in postmenopausal women? Menopause 2018;25:307–313.
  • Donini LM, Pinto A, Giusti AM, et al. Obesity or BMI paradox? Beneath the tip of the Iceberg. Front Nutr.2020;7:53.
  • Morigny P, Boucher J, Arner P, et al. Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics. Nat Rev Endocrinol. 2021. doi:https://doi.org/10.1038/s41574-021-00471-8
  • Blundell JE, Dulloo AG, Salvador J, et al. Beyond BMI – phenotyping the obesities. Obes Facts. 2014;7:322–328.
  • Blüher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab. 2013;27:163–177.
  • Longo M, Zatterale F, Naderi J, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019;20:2358.
  • Caputo T, Tran VDT, Bararpour N, et al. Anti-adipogenic signals at the onset of obesity-related inflammation in white adipose tissue. Cell Mol Life Sci. 2020. DOI:https://doi.org/10.1007/s00018-020-03485-z.
  • Torre-Villalvazo I, Bunt AE, Alemán G, et al. Adiponectin synthesis and secretion by subcutaneous adipose tissue is impaired during obesity by endoplasmic reticulum stress. J Cell Biochem. 2018;119:5970–5984.
  • Goossens GH. The metabolic phenotype in obesity: fat mass, body fat distribution, and adipose tissue function. Obes Facts. 2017;10:207–215.
  • Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav. 2008;94:206–218.
  • Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168:1617–1624.
  • Primeau V, Coderre L, Karelis AD, et al. Rabasa-Lhoret R: characterizing the profile of obese patients who are metabolically healthy. Int J Obes. 2011;35:971–981.
  • Stern JH, Rutkowski JM, Scherer PE. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab. 2016;23:770–784.
  • Friedman JM. Leptin and the endocrine control of energy balance. Nat Metab. 2019;1:754–764.
  • Frühbeck G, Catalán V, Rodríguez A, et al. Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk. Adipocyte. 2018;7:57–62.
  • Amato MC, Giordano C, Galia M, et al., AlkaMeSy Study Group. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33:920–922. .
  • Amato MC, Giordano C. Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol. 2014;2014:730827.
  • Oh S-K, Cho A-R, Kwon Y-J, et al. Derivation and validation of a new visceral adiposity index for predicting visceral obesity and cardiometabolic risk in a Korean population. PLoS One. 2018;13:e0203787.
  • Xia MF, Chen Y, Lin HD, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep. 2016;6:38214.
  • Villarreal-Molina T, Posadas-Romero C, Romero-Hidalgo S, et al. The ABCA1 gene R230C variant is associated with decreased risk of premature coronary artery disease: the genetics of atherosclerotic disease (GEA) study. PLoS One. 2012;7:e49285.
  • González-Salazar MC, Medina-Urrutia AX, Juárez-Rojas JG, et al. Dietary patterns and physical activity in the Mexican population: association with fatty liver. Gac Med Mex. 2014;150:39–47.
  • DeLong DM, DeLong ER, Wood PD, et al. A comparison of methods for the estimation of plasma low-and very low-density lipoprotein cholesterol: the lipid research clinics prevalence study. JAMA. 1986;256:2372–2377.
  • Rodriguez-Ayala E, Gallegos-Cabrales EC, Gonzalez-Lopez L, et al. Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family study. Adipocyte 2020;9:153–169.
  • Colletti PM, Dustin LD, Wong ND, et al. Does coronary calcium score predict future cardiac function? Association of subclinical atherosclerosis with left ventricular systolic and diastolic dysfunction at MR imaging in an elderly cohort. Radiology. 2010;257:64–70.
  • McKimmie RL, Daniel KR, Carr JJ, et al. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the diabetes heart study. Am J Gastroenterol. 2008;103:3029–3035.
  • American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2016;39:S13–S22.
  • Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 Jun;71(6):1269–1324. DOI: https://doi.org/10.1161/HYP.0000000000000066
  • Chachopoulos V, Dinas PC, Chasioti M, et al. Technique for subcutaneous abdominal adipose tissue biopsy via a non-diathermy method. J Vis Exp. 2017;127:55593.
  • Miladinovic D, Cusick T, Mahon KL, et al. Assessment of periprostatic and subcutaneous adipose tissue lipolysis and adipocyte size from men with localized prostate cancer. Cancers (Basel). 2020;12:1385.
  • Aguilar-Salinas CA, Olaiz G, Valles V, et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res. 2001;42:1298–1307.
  • Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11:11–18.
  • Strissel KJ, Stancheva Z, Miyoshi H, et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes. 2007;56:2910–2918.
  • Landgraf K, Rockstroh D, Wagner IV, et al. Evidence of early alterations in adipose tissue biology and function and its association with obesity-related inflammation and insulin resistance in children. Diabetes. 2015;64:1249–1261.